nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00984	0.291	CbGbCtD
Prochlorperazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00915	0.271	CbGbCtD
Prochlorperazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0042	0.124	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00413	0.122	CbGbCtD
Prochlorperazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00385	0.114	CbGbCtD
Prochlorperazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00303	0.164	CrCbGaD
Prochlorperazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.0777	CbGbCtD
Prochlorperazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.00249	0.134	CrCbGaD
Prochlorperazine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00188	0.00199	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00199	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00199	CcSEcCtD
Prochlorperazine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00187	0.00197	CcSEcCtD
Prochlorperazine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00187	0.00197	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00186	0.00196	CcSEcCtD
Prochlorperazine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00184	0.00194	CcSEcCtD
Prochlorperazine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00193	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00193	CcSEcCtD
Prochlorperazine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0018	0.0019	CcSEcCtD
Prochlorperazine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.0019	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00189	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00189	CcSEcCtD
Prochlorperazine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00188	CcSEcCtD
Prochlorperazine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00177	0.00187	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00186	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00186	CcSEcCtD
Prochlorperazine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Prochlorperazine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Prochlorperazine—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00174	0.00183	CcSEcCtD
Prochlorperazine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00183	CcSEcCtD
Prochlorperazine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00173	0.00182	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00182	CcSEcCtD
Prochlorperazine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00171	0.00181	CcSEcCtD
Prochlorperazine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.00181	CcSEcCtD
Prochlorperazine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00171	0.0018	CcSEcCtD
Prochlorperazine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.0018	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00179	CcSEcCtD
Prochlorperazine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00169	0.00178	CcSEcCtD
Prochlorperazine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00177	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00177	CcSEcCtD
Prochlorperazine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Prochlorperazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00166	0.00176	CcSEcCtD
Prochlorperazine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00166	0.00175	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00174	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00174	CcSEcCtD
Prochlorperazine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00173	CcSEcCtD
Prochlorperazine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00173	CcSEcCtD
Prochlorperazine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00173	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00172	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00172	CcSEcCtD
Prochlorperazine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00158	0.00167	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00166	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00156	0.00165	CcSEcCtD
Prochlorperazine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00165	CcSEcCtD
Prochlorperazine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00164	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00164	CcSEcCtD
Prochlorperazine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00163	CcSEcCtD
Prochlorperazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00154	0.00162	CcSEcCtD
Prochlorperazine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00154	0.00162	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00154	0.00162	CcSEcCtD
Prochlorperazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00153	0.00162	CcSEcCtD
Prochlorperazine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00161	CcSEcCtD
Prochlorperazine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00161	CcSEcCtD
Prochlorperazine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00152	0.0016	CcSEcCtD
Prochlorperazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00152	0.0016	CcSEcCtD
Prochlorperazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.0016	CcSEcCtD
Prochlorperazine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00151	0.0016	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Prochlorperazine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Prochlorperazine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00149	0.00157	CcSEcCtD
Prochlorperazine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00157	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00156	CcSEcCtD
Prochlorperazine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00146	0.00154	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00154	CcSEcCtD
Prochlorperazine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00154	CcSEcCtD
Prochlorperazine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00153	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00152	CcSEcCtD
Prochlorperazine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00151	CcSEcCtD
Prochlorperazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00143	0.00151	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00151	CcSEcCtD
Prochlorperazine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00142	0.0015	CcSEcCtD
Prochlorperazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00149	CcSEcCtD
Prochlorperazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00149	CcSEcCtD
Prochlorperazine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00149	CcSEcCtD
Prochlorperazine—Oedema—Vincristine—peripheral nervous system neoplasm	0.0014	0.00148	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.0014	0.00148	CcSEcCtD
Prochlorperazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0014	0.00147	CcSEcCtD
Prochlorperazine—Infection—Vincristine—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00146	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Prochlorperazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00144	CcSEcCtD
Prochlorperazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Prochlorperazine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Prochlorperazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00143	CcSEcCtD
Prochlorperazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00143	CcSEcCtD
Prochlorperazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00134	0.00142	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Prochlorperazine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Prochlorperazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Prochlorperazine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Prochlorperazine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00137	CcSEcCtD
Prochlorperazine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00137	CcSEcCtD
Prochlorperazine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00128	0.00135	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00135	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Prochlorperazine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Prochlorperazine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Prochlorperazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Prochlorperazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Prochlorperazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00131	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Prochlorperazine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00123	0.0013	CcSEcCtD
Prochlorperazine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00123	0.0013	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.0013	CcSEcCtD
Prochlorperazine—Rash—Topotecan—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Prochlorperazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Prochlorperazine—Cough—Etoposide—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Prochlorperazine—Headache—Topotecan—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Prochlorperazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Prochlorperazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Prochlorperazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Prochlorperazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Prochlorperazine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Prochlorperazine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Prochlorperazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Prochlorperazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Prochlorperazine—Domperidone—ABCB1—peripheral nervous system neoplasm	0.0012	0.065	CrCbGaD
Prochlorperazine—Constipation—Vincristine—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Prochlorperazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.0012	0.0648	CrCbGaD
Prochlorperazine—Rash—Melphalan—peripheral nervous system neoplasm	0.0012	0.00126	CcSEcCtD
Prochlorperazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0012	0.00126	CcSEcCtD
Prochlorperazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Prochlorperazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Prochlorperazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00122	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Prochlorperazine—Infection—Etoposide—peripheral nervous system neoplasm	0.00113	0.00119	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Prochlorperazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Prochlorperazine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.0011	0.00117	CcSEcCtD
Prochlorperazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00113	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Prochlorperazine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00103	0.00109	CcSEcCtD
Prochlorperazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00109	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000999	0.00105	CcSEcCtD
Prochlorperazine—Nefazodone—ABCB1—peripheral nervous system neoplasm	0.000999	0.054	CrCbGaD
Prochlorperazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000991	0.00105	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000985	0.00104	CcSEcCtD
Prochlorperazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000981	0.00104	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000974	0.00103	CcSEcCtD
Prochlorperazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000974	0.0526	CrCbGaD
Prochlorperazine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000972	0.00103	CcSEcCtD
Prochlorperazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000963	0.00102	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000947	0.000999	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000944	0.000996	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000936	0.000987	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000933	0.000984	CcSEcCtD
Prochlorperazine—Aripiprazole—ABCB1—peripheral nervous system neoplasm	0.000929	0.0502	CrCbGaD
Prochlorperazine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000928	0.000979	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.000976	CcSEcCtD
Prochlorperazine—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000924	0.05	CrCbGaD
Prochlorperazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.000969	CcSEcCtD
Prochlorperazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.000968	CcSEcCtD
Prochlorperazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000914	0.000965	CcSEcCtD
Prochlorperazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000913	0.000963	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000903	0.000953	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000901	0.000951	CcSEcCtD
Prochlorperazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000899	0.000948	CcSEcCtD
Prochlorperazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000885	0.000934	CcSEcCtD
Prochlorperazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000884	0.000933	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000884	0.000933	CcSEcCtD
Prochlorperazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000879	0.000928	CcSEcCtD
Prochlorperazine—Clobazam—ABCB1—peripheral nervous system neoplasm	0.000866	0.0468	CrCbGaD
Prochlorperazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.000911	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000848	0.000895	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000838	0.000884	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000818	0.000863	CcSEcCtD
Prochlorperazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000804	0.000849	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000801	0.000846	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000785	0.000828	CcSEcCtD
Prochlorperazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000783	0.000826	CcSEcCtD
Prochlorperazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000782	0.000825	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000781	0.000824	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000759	0.0008	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000752	0.000793	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000751	0.000792	CcSEcCtD
Prochlorperazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.000749	0.0405	CrCbGaD
Prochlorperazine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000783	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000736	0.000777	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.000763	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000757	CcSEcCtD
Prochlorperazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000717	0.000757	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000716	0.000756	CcSEcCtD
Prochlorperazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000712	0.000752	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000702	0.000741	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000738	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.000733	CcSEcCtD
Prochlorperazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.000685	0.037	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.000682	0.0369	CrCbGaD
Prochlorperazine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000682	0.000719	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.000719	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000677	0.000714	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000701	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00065	0.000686	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000683	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000637	0.000673	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000637	0.000673	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000633	0.000668	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000665	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000626	0.000661	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000659	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000619	0.000653	CcSEcCtD
Prochlorperazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000607	0.0328	CrCbGaD
Prochlorperazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.000635	CcSEcCtD
Prochlorperazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.000599	0.0324	CrCbGaD
Prochlorperazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000596	0.000628	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000622	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000622	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000618	CcSEcCtD
Prochlorperazine—Quetiapine—ABCB1—peripheral nervous system neoplasm	0.000581	0.0314	CrCbGaD
Prochlorperazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000609	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000608	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000604	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000568	0.0006	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000598	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000582	CcSEcCtD
Prochlorperazine—Desipramine—ABCB1—peripheral nervous system neoplasm	0.000551	0.0298	CrCbGaD
Prochlorperazine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000575	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000563	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000555	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000553	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000534	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000532	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000532	CcSEcCtD
Prochlorperazine—Clozapine—ABCB1—peripheral nervous system neoplasm	0.000499	0.027	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.00047	0.0254	CrCbGaD
Prochlorperazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00047	0.000496	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000494	CcSEcCtD
Prochlorperazine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000467	0.0253	CrCbGaD
Prochlorperazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.000492	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000476	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000458	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000445	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00044	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000424	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000424	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000421	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000412	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000392	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000392	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.00039	CcSEcCtD
